Exercise of Warrants and Total Voting Rights

RNS Number : 2143Z

Integumen PLC

16 September 2020

 

AIM share code: SKIN

16 August 2020

Integumen PLC

("Integumen" or "Company")

Exercise of Warrants  

Integumen announces that it has received notification from multiple warrant holders to exercise warrants over 42,500 shares in the share capital of Integumen ("the Warrant Shares") at an exercise price of 20 pence. T he consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of   £8,500.

Total voting rights

The Warrant Shares were allotted on 16 September 2020. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 22 September 2020. These shares will rank pari passu with the ordinary shares of the Company in issue.

The Company's total issued share capital, following the issue of the Warrant Shares, will be 113,185,643 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

Integumen plc	Gerard Brandon, CEO	[phone]
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Andrew Emmott	[phone]
Turner Pope Investments (TPI) Limited (Broker)	Andy Thacker/Zoe Alexander	[phone]

About Integumen plc:

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 

END

 

 

IOEGPURPBUPUGCQ